Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Innate lymphoid cells help us understand and manage allergic diseases better.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

Different parts of the body have unique immune characteristics in their skin.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

Angelica sinensis helps repair and regenerate the thymus in mice.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Stress can cause hair loss and trigger autoimmunity by damaging hair follicle cells.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

ILC1-like cells can independently cause alopecia areata.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

The treatment using a special hydrogel shows promise for promoting hair growth.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Cyclosporine effectively treated a woman's stubborn skin condition.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Entospletinib effectively prevents eye and skin GVHD in mice.

Pertussis toxin may contribute to hair loss in alopecia areata.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.